Compare ANIP & LEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | LEG |
|---|---|---|
| Founded | 2001 | 1883 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 1999 | 2018 |
| Metric | ANIP | LEG |
|---|---|---|
| Price | $74.21 | $9.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $110.00 | $10.50 |
| AVG Volume (30 Days) | 277.8K | ★ 1.1M |
| Earning Date | 05-08-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 2.06% |
| EPS Growth | ★ 419.23 | 145.31 |
| EPS | ★ 3.32 | 1.69 |
| Revenue | $206,547,000.00 | ★ $5,203,900,000.00 |
| Revenue This Year | $21.01 | N/A |
| Revenue Next Year | $17.59 | $2.85 |
| P/E Ratio | $22.36 | ★ $5.73 |
| Revenue Growth | ★ 2.47 | 1.37 |
| 52 Week Low | $56.71 | $6.48 |
| 52 Week High | $99.50 | $13.00 |
| Indicator | ANIP | LEG |
|---|---|---|
| Relative Strength Index (RSI) | 47.15 | 37.05 |
| Support Level | $72.43 | $9.50 |
| Resistance Level | $77.47 | $9.96 |
| Average True Range (ATR) | 2.10 | 0.32 |
| MACD | 0.37 | 0.03 |
| Stochastic Oscillator | 49.55 | 28.89 |
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the maximum of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.